Literature DB >> 50947

Motor neurone disease: an immunological study.

B F Tavolato, A C Licandro, A Saia.   

Abstract

The state of the immune system, both humoral and cell-mediated, was evaluated in motor neurone disease (MND) patients. The data obtained for the MND patients were confronted with normal controls and a group of patients affected by nervous diseases not involving the immune system. Some differences were observed between MND patients and normal subjects, namely: increase of WBC and gamma-globulin in MND patients. However, such differences were not observed between MND patients and pathological controls, and therefore are probably due to a higher frequency of infectious complications in MND patients in respect to normal controls. The capacity of the immune system to respond to an adequate stimulus was normal, and no precipitating anti-CNS antibodies were detected in MND sera. Furthermore, no sex-linked differences were observed and the CSF abnormalities observed in 2 out of 16 MND patients were probably reflecting only destruction of CNS cells. The data are discussed in view of the possible pathogenetic mechanisms of MND.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50947     DOI: 10.1159/000114699

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  3 in total

Review 1.  Immunology of amyotrophic lateral sclerosis.

Authors:  N R Cashman; M E Gurney; J P Antel
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Plasma exchange in motor neuron disease. A controlled study.

Authors:  I Monstad; I Dale; C F Petlund; O Sjaastad
Journal:  J Neurol       Date:  1979-07-11       Impact factor: 4.849

3.  Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens.

Authors:  H Bartfeld; C Dham; H Donnenfeld; L Jashnani; R Carp; R Kascsak; J Vilcek; M Rapport; S Wallenstein
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.